500 Participants Needed

Community-based Nurse-Guided Intervention for COVID-19 Recovery

SP
PC
PC
Overseen ByProgram Coordinator, MBA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medical University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to assist African American adults who have experienced severe COVID-19 and manage chronic health issues such as diabetes, high blood pressure, heart problems, kidney disease, or a history of stroke. The trial evaluates a nurse-guided community program, Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM), to see if it can enhance recovery and overall health for participants and their care partners. One group will participate in a 14-week telehealth program led by nurses and community health workers, while another group will receive general health advice via phone calls. Ideal participants are those who have been hospitalized or visited an ER for COVID-19 and reside in medically underserved or rural areas of South Carolina. As an unphased trial, this study provides a unique opportunity to contribute to community health improvements and receive personalized support.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this intervention is safe for participants?

Research has shown that the iCINGS FAM program, led by community nurses, has been used in similar situations without major safety issues. In a related study, the COVID-19 Care Companion Program achieved good results, including a 48% reduction in hospital visits, suggesting the program's likely safety.

The iCINGS FAM program involves community health workers and nurses assisting families through a telehealth program over several weeks. Although specific safety data for this exact program is unavailable, community and nurse-led healthcare programs are generally safe. These programs focus on teaching and support rather than medical procedures, which typically carry fewer risks.

Given the program's nature, it is likely safe for participants. However, discussing any concerns with the trial team or a doctor is always advisable.12345

Why are researchers excited about this trial?

Researchers are excited about the Community-based Nurse-Guided Intervention for COVID-19 Recovery because it takes a fresh approach by integrating family support with healthcare guidance through telehealth. Unlike standard treatments that often focus solely on individual medical care, this method emphasizes the role of family and community in recovery, coordinated by nurses and community health workers. This approach could provide more holistic and personalized care, potentially leading to better outcomes, especially for those who benefit from strong support systems. Additionally, the use of telehealth makes it accessible and convenient for participants who may have limited mobility or live in remote areas.

What evidence suggests that the iCINGS FAM intervention is effective for COVID-19 recovery in African American adults with chronic health conditions?

Research has shown that community-based programs led by nurses can significantly reduce hospital visits due to COVID-19. One past study demonstrated a 48% reduction in hospital visits with a similar program. In this trial, participants in the iCINGS FAM Intervention arm will undergo a 14-week, nurse-coordinated, Community Health Worker-supported telehealth intervention. This approach includes phone training for patients and their caregivers, enabling better health management at home. The program also aims to enhance COVID-19 testing and control, facilitating preventive measures. Community-focused strategies are crucial because they address local needs and priorities, increasing their effectiveness.12367

Who Is on the Research Team?

GS

Gayenell S Magwood, PhD

Principal Investigator

University of South Carolina

Are You a Good Fit for This Trial?

This trial is for African American adults over 18 living in medically underserved areas of South Carolina, with a history of COVID-19 hospitalization and chronic conditions like diabetes, hypertension, or heart disease. They must be caring for someone with similar health issues within a close proximity but cannot be paid caregivers.

Inclusion Criteria

I am either male or female.
I have been diagnosed with diabetes, high blood pressure, heart disease, kidney disease, or had a stroke over 3 months ago.
I was hospitalized due to COVID-19 after March 11th, 2020.
See 4 more

Exclusion Criteria

You are already taking part in other similar research studies.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Initial assessment of participants before randomization into intervention or control groups

1 week

Intervention

iCINGS FAM intervention with two planning sessions over 2 weeks followed by eight topic-guided sessions over 12 weeks

14 weeks
Weekly sessions for the first 4 weeks, then bi-weekly

Attention Control

Monthly scripted phone calls focused on general health risks and health promotion

3 months
3 phone calls (7-10 min each)

Follow-up

Participants are monitored for changes in health outcomes and behaviors at months 4 and 7

3 months
Follow-up assessments at month 4 and month 7

What Are the Treatments Tested in This Trial?

Interventions

  • Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)
Trial Overview The study examines the iCINGS FAM program's effectiveness in improving health outcomes for African Americans who have had COVID-19 and suffer from chronic illnesses, along with their informal carepartners.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: iCINGS Fam InterventionExperimental Treatment1 Intervention
Group II: Attention ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

University of South Carolina

Lead Sponsor

Trials
233
Recruited
122,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Published Research Related to This Trial

The COVID-19 Care Companion Program (CCP), a phone-based training intervention for patients and caregivers, significantly reduced hospitalizations by 48% within 21 days compared to standard care.
While the CCP did not show a significant effect on mortality rates, its ability to lower hospitalization rates suggests it could help alleviate pressure on healthcare systems during the pandemic.
Can training over phone calls help improve outcomes for COVID-19 positive patients under home isolation? An analysis of the COVID-19 Care Companion Program in Punjab, India.Murthy, S., Chandrasekar, A., Yan, SD., et al.[2023]
The Patient Stories Project (PSP) uses storytelling as a relational intervention to help COVID-19 survivors make sense of their illness and promote healing, revealing a pathway from feeling overwhelmed to regaining control and finding meaning in their experiences.
Qualitative interviews with six COVID-19 survivors identified key themes in their recovery, suggesting that storytelling can foster healthier relationships with themselves, families, and healthcare providers, and may support long-term recovery beyond the initial months.
Exploring the Impact of Storytelling for Hospitalized Patients Recovering from COVID-19.Gurney, L., Chung, V., MacPhee, M., et al.[2023]
Family members of critically ill COVID-19 patients experienced significant emotional and physical burdens, often facing their own health issues while being unable to visit or communicate effectively with their loved ones in the hospital.
After patients were discharged, family members felt a sudden shift in responsibility, highlighting the need for better support and communication throughout the patient's critical illness and recovery process.
Coping in times of disruption and deprivation-Experiences of family members during COVID-19 patients' critical illness: A qualitative study.Berntzen, H., Lind, R., Alfheim, H., et al.[2023]

Citations

Community-based Nurse-Guided Intervention for COVID ...The COVID-19 Care Companion Program (CCP), a phone-based training intervention for patients and caregivers, significantly reduced hospitalizations by 48% within ...
Exploring Barriers to Effective COVID-19 Risk Mitigation ...8 This formative study was designed to elicit stakeholder concerns, priorities, and preferences to tailor the iCINGS FAM intervention to COVID- ...
Integrated Community-Based Care for Dependent Older ...This study investigated the integration of community participatory systems in older care to address potential COVID-19 recurrence and develop policy proposals.
Patients, Families, and Communities COVID-19 Impact ...The report concluded that community-driven solutions are necessary, as communities are in a unique position to drive priorities and actions tailored to their ...
A Nurse-Community Health Worker-Family Partnership ...The study hypothesis is that the Nurse-CHW-Family Partnership intervention will improve household-level COVID-19 testing uptake, adoption of COVID control ...
The Impact of COVID-19 on the Nursing Workforce: A National ...The purpose of this article is to provide a comprehensive overview of the issues that the COVID-19 pandemic amplified and created in the nursing workforce ...
Surviving Covid-19 Diagnosis Among Registered NursesTo mitigate the spread of Covid-19, nurses infected with the virus were required to isolate themselves from their families and community.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security